vs
Side-by-side financial comparison of ONTO INNOVATION INC. (ONTO) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $218.2M, roughly 1.4× ONTO INNOVATION INC.). ONTO INNOVATION INC. runs the higher net margin — 12.9% vs 12.8%, a 0.1% gap on every dollar of revenue. On growth, Bio-Techne posted the faster year-over-year revenue change (-6.4% vs -13.5%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs 2.6%).
Onto Innovation Inc. is an American semiconductor company formed in 2019 from the merger of Rudolph Technologies, Inc. and Nanometrics Incorporated. It is a provider of process and process control equipment and software for microelectronic manufacturing industries.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
ONTO vs TECH — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $218.2M | $295.9M |
| Net Profit | $28.2M | $38.0M |
| Gross Margin | 50.7% | 64.6% |
| Operating Margin | 10.9% | 18.4% |
| Net Margin | 12.9% | 12.8% |
| Revenue YoY | -13.5% | -6.4% |
| Net Profit YoY | -46.8% | 68.3% |
| EPS (diluted) | $0.57 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $295.9M | ||
| Q3 25 | $218.2M | — | ||
| Q2 25 | $253.6M | $317.0M | ||
| Q1 25 | $266.6M | $316.2M | ||
| Q4 24 | $263.9M | $297.0M | ||
| Q3 24 | $252.2M | $289.5M | ||
| Q2 24 | $242.3M | $306.1M | ||
| Q1 24 | $228.8M | $303.4M |
| Q4 25 | — | $38.0M | ||
| Q3 25 | $28.2M | — | ||
| Q2 25 | $33.9M | $-17.7M | ||
| Q1 25 | $64.1M | $22.6M | ||
| Q4 24 | $48.8M | $34.9M | ||
| Q3 24 | $53.1M | $33.6M | ||
| Q2 24 | $52.9M | $40.6M | ||
| Q1 24 | $46.9M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | 50.7% | — | ||
| Q2 25 | 48.2% | 62.7% | ||
| Q1 25 | 53.7% | 67.9% | ||
| Q4 24 | 50.2% | 65.3% | ||
| Q3 24 | 54.1% | 63.2% | ||
| Q2 24 | 52.9% | 66.4% | ||
| Q1 24 | 51.7% | 67.4% |
| Q4 25 | — | 18.4% | ||
| Q3 25 | 10.9% | — | ||
| Q2 25 | 12.7% | -7.5% | ||
| Q1 25 | 23.7% | 12.2% | ||
| Q4 24 | 16.1% | 16.0% | ||
| Q3 24 | 21.0% | 13.8% | ||
| Q2 24 | 20.2% | 15.0% | ||
| Q1 24 | 18.7% | 22.1% |
| Q4 25 | — | 12.8% | ||
| Q3 25 | 12.9% | — | ||
| Q2 25 | 13.4% | -5.6% | ||
| Q1 25 | 24.0% | 7.1% | ||
| Q4 24 | 18.5% | 11.7% | ||
| Q3 24 | 21.0% | 11.6% | ||
| Q2 24 | 21.9% | 13.3% | ||
| Q1 24 | 20.5% | 16.2% |
| Q4 25 | — | $0.24 | ||
| Q3 25 | $0.57 | — | ||
| Q2 25 | $0.69 | $-0.11 | ||
| Q1 25 | $1.30 | $0.14 | ||
| Q4 24 | $0.98 | $0.22 | ||
| Q3 24 | $1.07 | $0.21 | ||
| Q2 24 | $1.07 | $0.26 | ||
| Q1 24 | $0.94 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $603.1M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $2.0B | $2.0B |
| Total Assets | $2.2B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $172.9M | ||
| Q3 25 | $603.1M | — | ||
| Q2 25 | $217.5M | $162.2M | ||
| Q1 25 | $203.7M | $140.7M | ||
| Q4 24 | $212.9M | $177.5M | ||
| Q3 24 | $188.7M | $187.5M | ||
| Q2 24 | $172.6M | $152.9M | ||
| Q1 24 | $190.9M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | — | $2.0B | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $2.0B | $1.9B | ||
| Q1 25 | $1.9B | $2.0B | ||
| Q4 24 | $1.9B | $2.1B | ||
| Q3 24 | $1.9B | $2.1B | ||
| Q2 24 | $1.8B | $2.1B | ||
| Q1 24 | $1.8B | $2.0B |
| Q4 25 | — | $2.5B | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $2.1B | $2.6B | ||
| Q1 25 | $2.1B | $2.6B | ||
| Q4 24 | $2.1B | $2.7B | ||
| Q3 24 | $2.1B | $2.7B | ||
| Q2 24 | $2.0B | $2.7B | ||
| Q1 24 | $2.0B | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $83.4M | — |
| Free Cash FlowOCF − Capex | $82.0M | — |
| FCF MarginFCF / Revenue | 37.6% | — |
| Capex IntensityCapex / Revenue | 0.6% | — |
| Cash ConversionOCF / Net Profit | 2.95× | — |
| TTM Free Cash FlowTrailing 4 quarters | $261.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $83.4M | — | ||
| Q2 25 | $57.9M | $98.2M | ||
| Q1 25 | $92.0M | $41.1M | ||
| Q4 24 | $56.0M | $84.3M | ||
| Q3 24 | $67.2M | $63.9M | ||
| Q2 24 | $65.3M | $75.5M | ||
| Q1 24 | $57.1M | $81.0M |
| Q4 25 | — | — | ||
| Q3 25 | $82.0M | — | ||
| Q2 25 | $44.2M | $93.3M | ||
| Q1 25 | $83.7M | $31.0M | ||
| Q4 24 | $51.4M | $77.5M | ||
| Q3 24 | $59.2M | $54.7M | ||
| Q2 24 | $53.0M | $57.5M | ||
| Q1 24 | $50.2M | $64.5M |
| Q4 25 | — | — | ||
| Q3 25 | 37.6% | — | ||
| Q2 25 | 17.4% | 29.4% | ||
| Q1 25 | 31.4% | 9.8% | ||
| Q4 24 | 19.5% | 26.1% | ||
| Q3 24 | 23.5% | 18.9% | ||
| Q2 24 | 21.9% | 18.8% | ||
| Q1 24 | 21.9% | 21.3% |
| Q4 25 | — | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 5.4% | 1.5% | ||
| Q1 25 | 3.1% | 3.2% | ||
| Q4 24 | 1.8% | 2.3% | ||
| Q3 24 | 3.2% | 3.2% | ||
| Q2 24 | 5.1% | 5.9% | ||
| Q1 24 | 3.0% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | 2.95× | — | ||
| Q2 25 | 1.71× | — | ||
| Q1 25 | 1.44× | 1.82× | ||
| Q4 24 | 1.15× | 2.42× | ||
| Q3 24 | 1.27× | 1.90× | ||
| Q2 24 | 1.23× | 1.86× | ||
| Q1 24 | 1.22× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ONTO
| Systems And Software Revenue | $173.8M | 80% |
| Parts Revenue | $23.9M | 11% |
| Service Revenue | $20.5M | 9% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
